How quickly can the CIOA model be established compared to surgical models?

Unlike DMM (Destabilization of the Medial Meniscus) models, which can take 8-12 weeks, CIOA shows significant inflammatory markers within days and structural damage within 2-4 weeks, allowing for faster drug screening.

What is the benefit of using Rabbit models over Rats for OA research?

Rabbits offer a larger joint volume, which is ideal for testing intra-articular medical devices or high-volume injectable formulations where surgical precision is paramount.

Are your behavioral tests sensitive enough to detect pain relief?

Absolutely. We utilize standardized mechanical allodynia and gait analysis platforms that correlate molecular inflammation with functional recovery.

Do you offer customized induction protocols?

Yes, we can adjust collagenase concentrations and injection frequencies to mimic specific disease stages as per your project requirements. Contact us to discuss your protocol.

Collagenase induced Osteoarthritis Modeling & Pharmacodynamics Service

Are you currently facing long R&D timelines and inconsistent results in joint disease modeling? Our Collagenase-Induced Osteoarthritis Modeling & Pharmacodynamics Service helps you validate therapeutic efficacy and obtain high-resolution pathology data through our proprietary Collagenase-Induced Osteoarthritis induction protocols and high-sensitivity evaluation platforms. We streamline your journey from lead optimization to IND-enabling studies using advanced bio-nanotechnology and rigorous longitudinal analysis.

Get a Quote

Overview of Collagenase-Induced Osteoarthritis Modeling

Osteoarthritis (OA) is a chronic, degenerative disorder of the synovial joints, characterized by the progressive breakdown of articular cartilage, subchondral bone remodeling, and chronic synovial inflammation. The physiological environment of the joint is maintained by a delicate balance of extracellular matrix (ECM) synthesis and degradation. In OA, this balance is disrupted, leading to the release of inflammatory cytokines like IL-6 and TNF-alpha, which further accelerate tissue destruction.

The Collagenase-Induced Osteoarthritis (CIOA) model is a premier "breakthrough" model in rheumatology research. By delivering a precise intra-articular injection of collagenase, we induce the proteolytic degradation of the collagen fibers within the ligaments and tendons. This creates joint instability and triggers a rapid inflammatory cascade that mimics the structural and molecular hallmarks of human OA, providing a robust environment for evaluating the pharmacodynamics of novel compounds.

Study overview. (OA Literature) Fig.1 Workflow of collagenase injection induced OA models.^1,3

Disease Models

Creative Biolabs offers highly validated CIOA models across rats and rabbits to suit your specific research objectives. By carefully controlling the dosage of Type VII or Type II collagenase, we can simulate varying degrees of disease severity, from mild cartilage fibrillation to total joint failure. Our standard workflow includes precise intra-articular needle placement under ultrasound or manual guidance to ensure localized induction. We provide comprehensive longitudinal data, beginning with the initial inflammatory surge and following through to chronic structural remodeling, allowing for precise drug-window targeting.

Evaluation Platform of Our Service

Creative Biolabs provides a multi-dimensional analysis suite that goes beyond simple histology. Our platform is designed to detect the subtle molecular shifts identified in recent high-impact research, such as the synergistic immune cell changes in synovial fluid.

Biochemical & Molecular Analysis:
- Cytokine Profiling: Multiplex assays.
- Protein Expression: Western Blot and ELISA for matrix metalloproteinases.
- Gene Expression: qPCR for Aggrecan and Collagen Type II mRNA levels.
Histopathological Examination:
- Staining: Safranin-O/Fast Green and H&E.
- Scoring Systems: Standardized OARSI and Mankin scoring for cartilage degradation.
- IHC: Immunohistochemical localization of ADAMTS-5 and inflammatory markers.
Behavioral & Functional Testing:
- Nociception: Von Frey filament testing for mechanical allodynia.
- Locomotion: Automated gait analysis (swing time, stance, and stride length).
- Physicality: Joint diameter measurement and weight-bearing distribution (Incapacitance testing).
Advanced Imaging & Instrumentation:
- Micro-CT: High-resolution 3D analysis of subchondral bone volume and osteophyte formation.
- Bone Mineral Density (BMD): Quantifying bone loss and mineralization changes.

Key Applications

Our CIOA models are engineered to simulate various clinical indications, including post-traumatic osteoarthritis (PTOA) and age-related joint degradation. These models are essential for evaluating:

Small Molecules: Testing systemic or local delivery of anti-inflammatory and analgesic compounds.
Biologics: Evaluating monoclonal antibodies, growth factors, and recombinant proteins.
Gene Therapies: Validating AAV- or mRNA-based interventions directly within the joint space.
Cell-Based Therapies: Monitoring the integration and paracrine effects of mesenchymal stem cells (MSCs).

Review Our Support Services - Schedule Your Consultation Today!

Why Choose Us?

Species Diversity

We offer fully validated Rat and Rabbit strains, ensuring your data is translatable and robust.

End-to-End Service

Our seamless transition from in vitro screening to in vivo PD/PK studies means you only need one partner for your entire discovery pipeline.

Scientific Expertise

Led by a PhD-level team, Creative Biolabs implements rigorous quality management systems that ensure every study meets international regulatory standards. Our integration of OARSI-recommended biomarkers ensures your results are industry-ready.

Uncover the Exclusive Advantages of Creative Biolabs - Request Your Quote Today!

Work with Us

Inquiry Stage

Summarize the project requirements and fill in the information collection form.
Sign a CDA from both parties to further communicate information, such as targets.
Select an animal model, discuss experimental design, and determine assay parameters.
Project costing and project schedule forecasting.

Project Start

We provide a detailed project plan, including the required sample quantities, methods, and protocols.
Both parties confirm the project details and start the project.
Confirm the timeline of the project.

Project Progress

We provide periodic results and information on the animal's condition.
We will work together to make project adjustments as necessary.

Project Completion

We provide a comprehensive project report promptly.
We arrange transportation for the produced samples.
We provide a discussion of the project results and help to arrange the next steps.

After-Sales Support

Data storage and archiving.

Frequently Asked Questions

Q: How quickly can the CIOA model be established compared to surgical models?

A: Unlike DMM (Destabilization of the Medial Meniscus) models, which can take 8-12 weeks, CIOA shows significant inflammatory markers within days and structural damage within 2-4 weeks, allowing for faster drug screening.
Q: What is the benefit of using Rabbit models over Rats for OA research?

A: Rabbits offer a larger joint volume, which is ideal for testing intra-articular medical devices or high-volume injectable formulations where surgical precision is paramount.
Q: Are your behavioral tests sensitive enough to detect pain relief?

A: Absolutely. We utilize standardized mechanical allodynia and gait analysis platforms that correlate molecular inflammation with functional recovery.
Q: Do you offer customized induction protocols?

A: Yes, we can adjust collagenase concentrations and injection frequencies to mimic specific disease stages as per your project requirements. Contact us to discuss your protocol.

Published Data

Objective: To characterize the temporal shifts in local and systemic immune cell populations during the progression of collagenase-induced joint inflammation.

Model Used: Rat CIOA model, induced via double intra-articular injection of collagenase.

Results: High-resolution flow cytometry and histopathological scoring revealed a significant influx of CD4⁺ Th17 cells and Ly6G⁺ neutrophils in the synovium by day 7. This correlated with a measurable decrease in Safranin-O staining intensity, indicating rapid proteoglycan loss. The model successfully validated the anti-inflammatory efficacy of a benchmark compound, demonstrating a 40% reduction in synovial thickness and improved weight-bearing capacity.

Histologic features of the knee joint after intra-articular injection of collagenase type IA. (OA Literature) Fig.2 Histological characteristics of the knee joint following intra-articular collagenase type IA injection.^2,3

Creative Biolabs is dedicated to providing the most precise and high-throughput Collagenase-Induced Osteoarthritis Modeling & Pharmacodynamics services in the industry. By combining surgical-level precision with advanced molecular analytics, we ensure your drug discovery program is backed by data that stands up to regulatory scrutiny. Our team of specialists is standing by to help you design your next OA study. Contact Our Team for More Information and to Discuss Your Project.

References

Weber, Patrick, et al. "The collagenase-induced osteoarthritis (CIOA) model: Where mechanical damage meets inflammation." Osteoarthritis and Cartilage Open 6.4 (2024): 100539. DOI: https://doi.org/10.1016/j.ocarto.2024.100539.
Boneva, Blagovesta, et al. "Collagenase-induced mouse model of osteoarthritis—a thorough flow cytometry analysis." Life 12.11 (2022): 1938. DOI: https://doi.org/10.3390/life12111938.
Distributed under Open Access license CC BY 4.0, without modification.